tiprankstipranks
Trending News
More News >

Jenscare Scientific Shows Promising Trial Results

Jenscare Scientific Shows Promising Trial Results

Jenscare Scientific Co. Ltd. Class H (HK:9877) has released an update.

Confident Investing Starts Here:

Jenscare Scientific Co. Ltd. reports a 40.64% reduction in loss before tax for the first half of 2024 compared to the previous year, alongside promising developments in their cardiac device trials, including positive results for their LuX-Valve Plus and JensClip products. The company is poised to seek regulatory approval for its LuX-Valve Plus, reflecting advancements in their product pipeline and operations.

For further insights into HK:9877 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1